Clinical trial
A Prospective Randomized, Blind, Placebo-controlled Trial "The Effectiveness of Transcranial Magnetic Stimulation of Supplementary Motor Area (SMA) in Patients With Bladder Hypersensitivity and Bladder Pain
NCT04721210 is registered in ClinicalTrials.gov with Joint-Stock Company North-West Center for Evidence-Based Medicine, Russian Federation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective Randomized, Blind, Placebo-controlled Trial "The Effectiveness of Transcranial Magnetic Stimulation of Supplementary Motor Area (SMA) in Patients With Bladder Hypersensitivity and Bladder Pain
- Lead sponsor
- Joint-Stock Company North-West Center for Evidence-Based Medicine, Russian Federation
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- January 20, 2021
- Completion date
- January 20, 2022
- Enrollment
- 28 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
bladder hypersensitivity